These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28093931)

  • 1. Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer.
    Yoshida H; Murono S; Ueno T; Nakanishi Y; Tsuji A; Hatano M; Endo K; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
    Acta Otolaryngol; 2017 Jul; 137(7):773-777. PubMed ID: 28093931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal human papillomavirus detection in palatine and pharyngeal tonsils.
    Murono S; Yoshida H; Kobayashi T; Kawase T; Kikuchi D; Suzuki T; Nakanishi Y; Endo K; Kondo S; Wakisaka N; Yoshizaki T
    Acta Otolaryngol; 2018 May; 138(5):483-486. PubMed ID: 29187118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
    Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral human papillomavirus (HPV) infection in HPV-positive patients with oropharyngeal cancer and their partners.
    D'Souza G; Gross ND; Pai SI; Haddad R; Anderson KS; Rajan S; Gerber J; Gillison ML; Posner MR
    J Clin Oncol; 2014 Aug; 32(23):2408-15. PubMed ID: 24778397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
    Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk human papillomavirus detection in oropharyngeal cancers: Comparison of saliva sampling methods.
    Tang KD; Kenny L; Frazer IH; Punyadeera C
    Head Neck; 2019 May; 41(5):1484-1489. PubMed ID: 30582230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Oral Human Papillomavirus DNA Persistence With Cancer Progression After Primary Treatment for Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Fakhry C; Blackford AL; Neuner G; Xiao W; Jiang B; Agrawal A; Gillison ML
    JAMA Oncol; 2019 Jul; 5(7):985-992. PubMed ID: 31046104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
    Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
    Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of HPV in oral rinse samples from OPSCC and non-OPSCC patients.
    Dang J; Feng Q; Eaton KD; Jang H; Kiviat NB
    BMC Oral Health; 2015 Oct; 15(1):126. PubMed ID: 26472641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
    Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
    J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus frequency in oral and oropharyngeal cancer in Greece.
    Romanitan M; Näsman A; Ramqvist T; Dahlstrand H; Polykretis L; Vogiatzis P; Vamvakas P; Tasopoulos G; Valavanis C; Arapantoni-Dadioti P; Banis K; Dalianis T
    Anticancer Res; 2008; 28(4B):2077-80. PubMed ID: 18751378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
    BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
    Rooper LM; Gandhi M; Bishop JA; Westra WH
    Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular Toll-Like Receptors Modulate Adaptive Immune Responses in Head and Neck Cancer.
    Nayanar SK; Roshan V G D; Surendran S; Kjeller G; Hasséus B; Giglio D
    Viral Immunol; 2023 Dec; 36(10):659-668. PubMed ID: 38064542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of human papillomavirus cell-free DNA from low-volume blood plasma samples by digital PCR.
    Rosing F; Meier M; Schroeder L; Laban S; Hoffmann T; Kaufmann A; Siefer O; Wuerdemann N; Klußmann JP; Rieckmann T; Alt Y; Faden DL; Waterboer T; Höfler D
    Microbiol Spectr; 2024 Jul; 12(7):e0002424. PubMed ID: 38829114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral testing for high-risk human papillomavirus DNA and E6/E7 messenger RNA in healthy individuals at risk for oral infection.
    Rollo F; Pichi B; Benevolo M; Giuliani M; Latini A; Lorenzon L; Colafigli M; Frasca M; Pellini R; Cristaudo A; Donà MG
    Cancer; 2019 Aug; 125(15):2587-2593. PubMed ID: 31034590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics.
    Giuliano AR; Nedjai B; Lorincz AT; Schell MJ; Rahman S; Banwait R; Boulware D; Sirak B; Martin-Gomez L; Abrahamsen M; Isaacs-Soriano KA; Wenig B; Chung CH; Caudell J
    Int J Cancer; 2020 Feb; 146(4):1018-1030. PubMed ID: 31304592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.